Kimera Labs Advances in Healthy Aging with $101 Million XPRIZE Healthspan Semifinalist Recognition Kimera Labs, a leader in therapeutic exosome biotechnology, proudly announces its semifinalist position in the prestigious $101 million XPRIZE Healthspan competition, aiming to enhance healthy human lifespans.

Kimera Labs Advances in Healthy Aging with $101 Million XPRIZE Healthspan Semifinalist Recognition #USA #Miramar #Kimera_Labs #Exosome_Biotechnology #Healthspan_Competition

Kimera Labs: A Semifinalist in the Prestigious XPRIZE Healthspan Competition for Healthy Aging Innovations Kimera Labs has been recognized as a semifinalist in the $101 million XPRIZE Healthspan competition. The company's innovations mark a significant step in extending healthy human lifespan.

Kimera Labs: A Semifinalist in the Prestigious XPRIZE Healthspan Competition for Healthy Aging Innovations #USA #XPRIZE #Miramar #Healthy_Aging #Kimera_Labs

Kimera Labs Achieves Semifinalist Status in $101 Million XPRIZE Healthspan Challenge Kimera Labs has been honored as a semifinalist in the prestigious $101 million XPRIZE Healthspan competition, emphasizing their innovations in healthy aging through therapeutic exosomes.

Kimera Labs Achieves Semifinalist Status in $101 Million XPRIZE Healthspan Challenge #USA #XPRIZE #Miramar #Healthspan #Kimera_Labs